KRT19 and cholangiocarcinoma: Different types of cancer cells have different characteristic combinations of cytokeratin (CK), in which hepatocytes and common hepatocellular carcinoma usually express CK8 and CK18, while cholangiocytes and cholangiocarcinoma usually express CK7 and CK19.